Literature DB >> 26924305

Immunobiology in VCA.

Christina L Kaufman1, Michael R Marvin2, Paula M Chilton1, James B Hoying3, Stuart K Williams3, Huey Tien1, Tuna Ozyurekoglu1, Rosemary Ouseph4.   

Abstract

Transplantation of vascularized composite tissue is a relatively new field that is an amalgamation of experience in solid organ transplantation and reconstructive plastic and orthopedic surgery. What is novel about the immunobiology of VCA is the addition of tissues with unique immunologic characteristics such as skin and vascularized bone, and the nature of VCA grafts, with direct exposure to the environment, and external forces of trauma. VCAs are distinguished from solid organ transplants by the requirement of rigorous physical therapy for optimal outcomes and the fact that these procedures are not lifesaving in most cases. In this review, we will discuss the immunobiology of these systems and how the interplay can result in pathology unique to VCA as well as provide potential targets for therapy.
© 2016 Steunstichting ESOT.

Entities:  

Keywords:  T regulatory cells; face transplantation; hand transplantation; immunomodulation; vasculopathy

Mesh:

Year:  2016        PMID: 26924305     DOI: 10.1111/tri.12764

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  11 in total

Review 1.  Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.

Authors:  Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

Review 2.  Accommodation and related conditions in vascularized composite allografts.

Authors:  Jeffrey L Platt; Christina L Kaufman; Mayara Garcia de Mattos Barbosa; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2017-10       Impact factor: 2.640

3.  Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts.

Authors:  Laura C Burlage; Alexandre G Lellouch; Corentin B Taveau; Philipp Tratnig-Frankl; Casie A Pendexter; Mark A Randolph; Robert J Porte; Laurent A Lantieri; Shannon N Tessier; Curtis L Cetrulo; Korkut Uygun
Journal:  J Surg Res       Date:  2021-10-17       Impact factor: 2.192

4.  Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.

Authors:  Christina L Kaufman; Jean Kanitakis; Annemarie Weissenbacher; Gerald Brandacher; Mandeep R Mehra; Hatem Amer; Bettina G Zelger; Bernhard Zelger; Bohdan Pomahac; Sue McDiarmid; Linda Cendales; Emmanuel Morelon
Journal:  SAGE Open Med       Date:  2020-07-14

5.  Efficacy of single-agent immunosuppressive regimens in a murine model of vascularized composite allotransplantation.

Authors:  Yinan Guo; Franka Messner; Byoung Chol Oh; Gerald Brandacher; Joanna W Etra; Sarah E Beck; Richa Kalsi; Georg J Furtmüller; Stefan Schneeberger
Journal:  Transpl Int       Date:  2020-05-12       Impact factor: 3.782

6.  The Evolving Clinical Presentation of Acute Rejection in Facial Transplantation.

Authors:  Valentin Haug; Branislav Kollar; Doha Obed; Harriet Kiwanuka; Marvee Turk; Luccie Wo; Sotirios Tasigiorgos; Maximillian Kueckelhaus; Leonardo V Riella; Bohdan Pomahac
Journal:  JAMA Facial Plast Surg       Date:  2019-07-01       Impact factor: 4.611

Review 7.  Composite tissue allotransplantation: opportunities and challenges.

Authors:  Jasper Iske; Yeqi Nian; Ryoichi Maenosono; Max Maurer; Igor M Sauer; Stefan G Tullius
Journal:  Cell Mol Immunol       Date:  2019-03-06       Impact factor: 11.530

8.  Infrared imaging of lymphatic function in the upper extremity of normal controls and hand transplant recipients via subcutaneous indocyanine green injection.

Authors:  Efrain Farias-Cisneros; Paula M Chilton; Michelle D Palazzo; Tuna Ozyurekoglu; Jay B Hoying; Stuart K Williams; Carter Baughman; Christopher M Jones; Christina L Kaufman
Journal:  SAGE Open Med       Date:  2019-07-08

9.  MMP3 Is a Non-invasive Biomarker of Rejection in Skin-Bearing Vascularized Composite Allotransplantation: A Multicenter Validation Study.

Authors:  Branislav Kollar; Audrey Uffing; Thiago J Borges; Andrey V Shubin; Bruno T Aoyama; Céline Dagot; Valentin Haug; Martin Kauke; Ali-Farid Safi; Simon G Talbot; Emmanuel Morelon; Stéphanie Dakpe; Bohdan Pomahac; Leonardo V Riella
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

10.  Increased levels of circulating MMP3 correlate with severe rejection in face transplantation.

Authors:  Branislav Kollar; Andrey Shubin; Thiago J Borges; Sotirios Tasigiorgos; Thet Su Win; Christine G Lian; Simon T Dillon; Xuesong Gu; Iris Wyrobnik; George F Murphy; Bohdan Pomahac; Towia A Libermann; Leonardo V Riella
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.